The largest database of trusted experimental protocols

66 protocols using pcmv6 ac gfp

1

Plasmid Constructs for Studying Neurodegenerative Diseases

Check if the same lab product or an alternative is used in the 5 most similar protocols
M337V human TDP-43 cDNA was cloned into pCMV6-AC-GFP (Origene) to generate a mutant TDP-43 construct C-terminally tagged with tGFP18 (link). HA-NFAT1(1-460)-GFP was a gift from Anjana Rao (Addgene plasmid #11107). Huntingtin protein-encoding constructs, pT-Rex-Htt46Q-Tc1-mCherry and pT-Rex-Htt25Q-Tc1-mCherry, were gifts from Dr. Danny Hatters (University of Melbourne, Australia)19 (link). pEGFP-SOD1, pEGFP-SOD1-A4V, pEGFP-SOD1-G93A were gifts from Dr. Brad Turner (The Florey Institute of Neuroscience and Mental Health, Australia)20 (link). SOD1-tdTomato constructs were created by replacing the GFP sequences in the SOD1-GFP plasmids with tdTomato (Genscript)18 (link). The expression vector pCMV6-AC-GFP containing FUS was obtained from Origene and site directed mutagenesis was performed by Genscript to create the R495X mutant18 (link). Plasmids containing sequences encoding wild type (WT) and temperature-sensitive double mutant (R188Q, R261Q; DM) firefly luciferase-eGFP were a gift from Prof Ulrich Hartl (Max Plank Institute, Germany)21 and were recloned into pcDNA4/TO (Life Technologies) for mammalian cell transfection.
+ Open protocol
+ Expand
2

Transfection of NSCs with SOX21 Vector

Check if the same lab product or an alternative is used in the 5 most similar protocols
Lipofectamine 3000 reagent (Thermo Fisher Scientific, MA, USA) was used to transfect NSCs with mammalian vector pCMV6-AC-GFP containing SOX21 (NM_177753) Mouse Tagged ORF Clone (No: MG223510) or blank control pCMV6-AC-GFP (No: PS100010, OriGene Technologies, Inc. Rockville, MD, USA), according to the manufacturer’s instructions.
+ Open protocol
+ Expand
3

AAV-Mediated Overexpression of Scf and Ptbp1 in Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
The AAV delivery system was used to overexpress soluble Scf-aequorea coerulescens GFP (acGFP) or Ptbp1T138E-acGFP or acGFP in mouse. We first amplified the CMV-acGFP cassette from pCMV6-AC-GFP (Origene, #PS100010) and cloned it into pAAV.CMV.PI.GFP.WPRE.bGH (Addgene, #105530) by replacing the CMV-chimeric intron-EGFP following digestion with NheI and HindIII. Then we cloned EC-specific promoter of Flt-1 (2748 to 284) into this construct by replacing CMV promoter with NheI and SalI restriction enzymes according to a previous report48 (link) to create the construct pAAV-Flt1-acGFP. The open reading frame (ORF) encoding soluble Scf or Ptbp1, without a stop codon, was cloned into pAAV-Flt1-acGFP following digestion with SalI and MluI to create pAAV-Flt1-sScf-acGFP or pAAV-Flt1-Ptbp1-acGFP, respectively. Vector pAAV-Flt1-acGFP served as a control. The AAV2 vector was generated by transfecting HEK293T cells with three plasmids (pAAV-Flt1-derived plasmid, AAV2 rep and cap genes plasmid, and the pAd helper plasmid). Titers of vector DNA were measured by quantitative PCR with vector-specific primers. Mice were injected with 100 μl virus containing 1011 AAV2 vector genomes via the tail vein.
+ Open protocol
+ Expand
4

HeLa Cells Transfection and Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
HeLa Kyoto cells were grown in 6-well culture dishes for 24 h in complete medium at 37°C in 5% CO2. Afterward, cells were transfected with a human RNF11 cDNA clone carboxy-terminally linked to turboGFP (pCMV6-AC-GFP; OriGene) using FuGENE6 (Roche) according to the manufacturer’s instructions. 24 h after transfection, cells were lysed and used for Q-RT-PCR experiments or fixed and immunostained.
+ Open protocol
+ Expand
5

Plasmid Propagation and Subcloning Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Plasmids were propagated in E. coli, extracted and purified using a Labopass plasmid DNA purification kit (Cosmo Genetech, Seoul, Korea). Full-length human ERGIC3 (GenBank ID:NM_015966.2) was subcloned in pCMV6-AC-GFP (OriGene Technologies Inc., Rockville, MD, USA), pCMV-Myc (Clontech Laboratories Inc., Palo Alto, CA, USA) or pGBKT7 (Clontech) plasmid vectors. ERGIC3 shRNAs were purchased from OriGene.
+ Open protocol
+ Expand
6

Overexpression of MSI2 in Breast Cancer

Check if the same lab product or an alternative is used in the 5 most similar protocols
A total of 5 μg MSI2-GFP and GFP vectors (pCMV6-MSI2-AC-GFP and pCMV6-AC-GFP from Origene, Rockville, MD, USA) were transfected into MCF7 and MDA-MB-231 cells (source: ATCC) using endofectin transfection reagent (Genocopoeia, Rockville, MD, USA) according to the manufacturer’s instructions. Expression was determined by fluorescence microscopy, western immunoblotting and qRT-PCR. Cell lines were authenticated and quality controlled at ATCC.
+ Open protocol
+ Expand
7

Generating SLC25A1 Mutant Constructs

Check if the same lab product or an alternative is used in the 5 most similar protocols
The coding sequence of the SLC25A1 gene was recloned from pCMV6-AC-GFP (Origene, Rockville, MD, USA) into the pEGFP-N1 vector (Clontech). Subsequently, the enhanced green fluorescent protein (EGFP) was removed from the vector, as it interfered with protein function. For each of the 17 missense mutations included in this study, recombinant plasmids were generated by site-directed mutagenesis, as previously described (Betsalel et al. 2012 (link)). Successful mutagenesis and absence of PCR artifacts was confirmed by full-length sequencing of the SLC25A1 coding sequence.
+ Open protocol
+ Expand
8

Transfection of MBOAT7 Plasmid in MDMs

Check if the same lab product or an alternative is used in the 5 most similar protocols
MBOAT7 plasmid (pCMV6-AC-MBOAT7-GFP, OriGene) and its empty cloning vector pCMV6-ACGFP, OriGene) were transfected into MDMs using a Nucleofector kit (Amaxa) as per manufacturer’s instructions for 48 h. Small interfering RNA (siRNA) transfection was performed with Lipofectamine RNAiMAX (Invitrogen) according to the manufacturer’s instructions using 50 nM of the specific siRNA or non-targeting control for 48 h.
+ Open protocol
+ Expand
9

Generation of Protein Expression Constructs

Check if the same lab product or an alternative is used in the 5 most similar protocols
The pEGFP-N1 vectors containing human SOD1wt, SOD1A4V and G93A SOD1 were generated as described65 (link). Expression vector pCMV6-AC-GFP containing human TDP-43 and FUS was obtained from OriGene (USA). SOD1-tomato constructs were generated by replacing the GFP sequences in the GFP-tagged constructs65 (link) with the tomato red fluorescent protein. TDP-43wt-tomato (Addgene plasmid 28205, provided by Zuoshang Xu34 (link)), mRFP-Ubiquitin (Addgene plasmid 11935, provided by Nico Dantuma66 (link)) and pmRFP-LC3 (Addgene plasmid 21075, Provided by Tamotsu Yoshimori67 (link)) constructs were acquired from Addgene (USA). The vectors describing Httex1(46Q) fusions (C-terminally) to mCherry and Cerulean were generated as described33 (link)68 (link).
+ Open protocol
+ Expand
10

Overexpression of OSM and CNTF in Breast Cancer Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
MCF7 cells with empty vector and OSM/CNTF overexpression were established
by transduction using these expression plasmids: pCMV3-C-GFPSpark Vector (Sino
Biologcial, Catalog Number CV026), pCMV3-C-OSM-GFP (Sino Biologcial, Catalog
Number HG10452-ACG), pCMV6-AC-GFP (Origene, Catalog Number PS100010) and
pCMV6-AC-CNTF-GFP (Origene, Catalog Number RG222331). Cells were selected using
hygromycin (OSM) and neomycin (CNTF). MDA-MB-231 parental and bone metastatic
cells transiently overexpressing OSM and CNTF were established using previously
mentioned expression vectors. Cells were transfected using Lipofectamine LTX
with Plus Reagent (Thermo Fisher, Catalog Number 15338030) and harvested 36
hours later.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!